Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging

scientific article published on February 2000

Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/ARD.59.2.135
P932PMC publication ID1753076
P698PubMed publication ID10666170
P5875ResearchGate publication ID277511810

P2093author name stringHamm B
Fischer T
Braun J
Sieper J
Bollow M
Backhaus M
Reisshauer H
P2860cites workThe European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathyQ34016674
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteriaQ34055060
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitisQ34058697
Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind studyQ39463480
Clinical History as a Screening Test for Ankylosing SpondylitisQ39812250
Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both?Q40375297
The sacroiliac joint in the spondyloarthropathies.Q41157885
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.Q50913336
Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI.Q52290112
Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging.Q53007008
Early sacroiliitis in patients with spondyloarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging.Q53013040
Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patientsQ72044965
P4510describes a project that usesmagnetic resonance imagingQ161238
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)135-140
P577publication date2000-02-01
P1433published inAnnals of the Rheumatic DiseasesQ4767876
P1476titleQuantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging
P478volume59

Reverse relations

cites work (P2860)
Q8430891218F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis
Q49119264A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations
Q46439316Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis
Q42616837Adalimumab for the treatment of ankylosing spondylitis
Q34994482Advances in the understanding of entheseal inflammation
Q35554475Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems
Q35555515Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis
Q61628504Ankylosierende Spondylitis
Q54165668Ankylosing spondylitis
Q39185886Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23.
Q35585432Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response
Q88013479Ankylosing spondylitis monocyte-derived macrophages express increased level of A2A adenosine receptor and decreased level of ectonucleoside triphosphate diphosphohydrolase-1 (CD39), A1 and A2B adenosine receptors
Q24675044Ankylosing spondylitis: an overview
Q40409369Anti-TNF agents for the treatment of spondyloarthropathies
Q37729028Anti-TNF-alpha therapy with infliximab in spondyloarthritides
Q51058288Assessment of active and inactive sacroiliitis in patients with ankylosing spondylitis using quantitative dynamic contrast-enhanced MRI.
Q86391201Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging
Q56899371Biomarkers in spondyloarthritis
Q38593977Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
Q47144866Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis
Q33520660Bone marrow edema: definition, diagnostic value and prognostic value
Q45299337Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort
Q48931896Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints
Q33390403Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study
Q37279934Clinical observations programme in SpA: disease parameters, treatment options and practical management issues
Q52710782Clinical utility of eco-color-power Doppler ultrasonography and contrast enhanced magnetic resonance imaging for interpretation and quantification of joint synovitis: a review.
Q35605658Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis
Q53340748Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.
Q34108703Cytokines and the immunopathology of the spondyloarthropathies
Q61628490DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen
Q64239345Deregulation of microRNA expression in monocytes and CD4 T lymphocytes from patients with axial spondyloarthritis
Q39874212Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial
Q51249813Diffusion-weighted imaging is a sensitive biomarker of response to biologic therapy in enthesitis-related arthritis.
Q35555116Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
Q95725541Effect of Icariin on apoptosis and expression of Fas, Fas ligand, B cell lymphoma, and Bcl-2-associated X protein in CD4+ T lymphocytes from patients with ankylosing spondylitis
Q24674877Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis
Q40204477Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients
Q38068578Emerging drugs for axial spondyloarthritis including ankylosing spondylitis
Q26775660Enthesopathies and enthesitis. Part 2: Imaging studies
Q51534462Evaluation of MR imaging guided steroid injection of the sacroiliac joints for the treatment of children with refractory enthesitis-related arthritis.
Q44616895Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies
Q42597088Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis.
Q33923744Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulation
Q38465941Gene expression profiling analysis of patients with ankylosing spondylitis
Q41101834Genetic and Functional Associations with Decreased Anti-inflammatory Tumor Necrosis Factor Alpha Induced Protein 3 in Macrophages from Subjects with Axial Spondyloarthritis
Q52853158Granulation Tissue Eroding the Subchondral Bone Also Promotes New Bone Formation in Ankylosing Spondylitis.
Q46646694High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis
Q36171850High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone
Q56957220Histomorphologic and histomorphometric characteristics of zygapophyseal joint remodeling in ankylosing spondylitis
Q37121649How does imaging help the clinician in the evaluation and management of spondyloarthritis?
Q46043893IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells
Q49712215Identification of potential target genes for ankylosing spondylitis treatment
Q37356387Imaging in rheumatology: reconciling radiology and rheumatology
Q35688985Imaging in spondyloarthropathies
Q50109015Imaging of the sacroiliac joints
Q42290440Immunohistological analysis of active sacroiliitis in patients with axial spondyloarthritis
Q35637293Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases
Q91894574Increased BMPR1A Expression Enhances the Adipogenic Differentiation of Mesenchymal Stem Cells in Patients with Ankylosing Spondylitis
Q80216692Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis
Q38070027Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective
Q36210882Infliximab for the treatment of ankylosing spondylitis
Q35637051Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up.
Q47710797M2 polarization of monocytes in ankylosing spondylitis and relationship with inflammation and structural damage
Q37228838MRI in psoriatic arthritis: insights into pathogenesis and treatment response
Q22000866Magnetic resonance imaging in psoriatic arthritis: a review of the literature
Q36577527Mechanisms of Disease: the immunopathogenesis of spondyloarthropathies
Q77641935Methotrexate in the treatment of ankylosing spondylitis
Q34560574New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy.
Q35164736Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides
Q26777906Old and new treatment targets in axial spondyloarthritis
Q42604065Opinion: Perspectives on imaging in axial spondyloarthritis
Q38109578Osteoimmunology and bone homeostasis: relevance to spondyloarthritis
Q99564754Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis
Q74531640Pathogenesis of reactive arthritis
Q37516572Progress in spondylarthritis. Spondyloarthritis: lessons from imaging
Q37014104Psoriatic disease--from skin to bone
Q61628518Rheumatoid arthritis of the shoulder joint: Comparison of conventional radiography, ultrasound, and dynamic contrast-enhanced magnetic resonance imaging
Q38014263Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature
Q36638774Severe bone marrow edema on sacroiliac joint MRI increases the risk of low BMD in patients with axial spondyloarthritis
Q36394657Simultaneous Quantification of Bone Edema/Adiposity and Structure in Inflamed Bone Using Chemical Shift-Encoded MRI in Spondyloarthritis
Q37279373Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics
Q40577128Synovitis in spondyloarthritides
Q57673802T-cell responses to versican in ankylosing spondylitis
Q37353874The efficacy and safety of rituximab in a patient with rheumatoid spondylitis
Q37918963The impact of MRI on the clinical management of inflammatory arthritides.
Q36519068The treatment of the rheumatological manifestations of the inflammatory bowel diseases
Q24806367Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches
Q36245711Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides
Q34071316Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences
Q34967507Treatment trials in ankylosing spondylitis: current and future considerations.
Q36960221Undifferentiated spondyloarthritis: a global perspective
Q36365524Vertebral body corner oedema vs gadolinium enhancement as biomarkers of active spinal inflammation in ankylosing spondylitis.
Q83350596[Bone marrow edema in magnetic resonance imaging. A misleading term?]
Q84600024[Effectiveness of biological agents in ankylosing spondylitis]
Q80404389[Epidemiology and prognostic aspects of ankylosing spondylitis]
Q52920765[Immunopathology of ankylosing spondylitis and other spondyloarthritides].
Q83350621[MRI examinations for axial and peripheral spondyloarthritis]
Q52943546[Magnetic resonance tomography of sacroiliitis: anatomy, histological pathology, MR-morphology, and grading].
Q81376497[Modern treatment of ankylosing spondylitis]
Q84600865[Sacroiliac joints: osteoarthritis or arthritis]
Q79314615[Spondylarthritides]

Search more.